{"antibody": ["alemtuzumab", "bevacizumab", "brentuximab vedotin", "cetuximab", "gemtuzumab ozogamicin", "panitumumab", "rituximab"], "brand name": ["campath", "avastin", "adcetris", "erbitux", "mylotarg", "vectibix", "rituxan , mabthera"], "approval date": ["2001", "2004", "2011", "2004", "2000", "2006", "1997"], "type": ["humanized", "humanized", "chimeric", "chimeric", "humanized", "human", "chimeric"], "target": ["cd52", "vascular endothelial growth factor", "cd30", "epidermal growth factor receptor", "cd33", "epidermal growth factor receptor", "cd20"], "approved treatment (s)": ["chronic lymphocytic leukemia", "colorectal cancer", "hodgkin lymphoma , anaplastic large - cell lymphoma", "colorectal cancer", "acute myelogenous leukemia (with calicheamicin )", "colorectal cancer", "non - hodgkin lymphoma"]}